Clinical Trial Update: Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study evaluated the efficacy and safety of ID1201 in patients with mild Alzheimer's disease and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ID1201

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED